Chih-Peng Liu

Synthesis and structure–activity relationship of 6-arylureido-3-pyrrol-2-ylmethylideneindolin-2-one derivatives as potent receptor tyrosine kinase inhibitors

Rahul R. Khanwelkar, Grace Shiahuy Chen, Hsiao-Chun Wang et al. · Bioorganic & Medicinal Chemistry · 2010 · 28 citations · Full text

Structure–activity Relationship, Medicinal Chemistry, Biochemistry +8

Novel azulene-based derivatives as potent multi-receptor tyrosine kinase inhibitors

Chih‐Hung Chen, On Lee, Chung-Niang Yao et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 26 citations · Full text

Medicinal Chemistry, Medicine, Rational Drug Design +6

A Highly Selective Rho-Kinase Inhibitor (ITRI-E-212) Potentially Treats Glaucoma Upon Topical Administration With Low Incidence of Ocular Hyperemia

Cherng-Ru Hsu, Yi‐Hsun Chen, Chih-Peng Liu et al. · Investigative Ophthalmology & Visual Science · 2019 · 25 citations · Full text

Bioisosteric replacement of an acylureido moiety attached to an indolin-2-one scaffold with a malonamido or a 2/4-pyridinoylamido moiety produces a selectively potent Aurora-B inhibitor

Hsiao-Chun Wang, Ajit Dhananjay Jagtap, Pei‐Teh Chang et al. · European Journal of Medicinal Chemistry · 2014 · 20 citations · Full text

Bioisosteric Replacement, Combinatorial Chemistry, Medicinal Chemistry +11

Inhibition of Retinal Ganglion Cell Loss By a Novel ROCK Inhibitor (E212) in Ischemic Optic Nerve Injury Via Antioxidative and Anti-Inflammatory Actions

Yao‐Tseng Wen, Ching-Wen Huang, Chih-Peng Liu et al. · Investigative Ophthalmology & Visual Science · 2021 · 19 citations · Full text